Katherine High
Director/Board Member presso CRISPR THERAPEUTICS AG
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Katherine A.
High was the founder of Spark Therapeutics, Inc. founded in 2013, where she held the title of President, Head-Research & Development.
Currently, she holds the position of Independent Director at Incyte Corp.
and CRISPR Therapeutics AG.
She is also a Director at Virion Therapeutics LLC and Innovative Genomics Institute.
In the past, she held the position of Director & President-Therapeutics at Asklepios BioPharmaceutical, Inc. from 2021 to 2022.
She was the Director of the Center for Cellular at The Children's Hospital of Philadelphia from 2004 to 2014 and a Professor at Perelman School of Medicine from 1999 to 2014.
She also served as the President of the American Society of Gene & Cell Therapy.
Dr. High received her undergraduate degree from Harvard University, her graduate degree from the University of Pennsylvania, and her doctorate from UNC School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
INCYTE CORPORATION
0.02% | 14/06/2023 | 36 926 ( 0.02% ) | 2 M $ | 31/03/2024 |
CRISPR THERAPEUTICS AG
-.--% | 08/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Katherine High
| Società | Posizione | Inizio |
|---|---|---|
| CRISPR THERAPEUTICS AG | Director/Board Member | 11/06/2019 |
| INCYTE CORPORATION | Director/Board Member | 25/03/2020 |
Virion Therapeutics LLC
 Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE. | Director/Board Member | - |
| Innovative Genomics Institute | Director/Board Member | - |
Precedenti posizioni note di Katherine High
| Società | Posizione | Fine |
|---|---|---|
Asklepios BioPharmaceutical, Inc.
 Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Director/Board Member | 01/12/2022 |
| SPARK THERAPEUTICS, INC. | Founder | 01/02/2020 |
| Perelman School of Medicine | Corporate Officer/Principal | 01/09/2014 |
The Children's Hospital of Philadelphia
 The Children's Hospital of Philadelphia Hospital/Nursing ManagementHealth Services The Children's Hospital of Philadelphia provides health care services. It specializes in pediatrics, research, fetal surgery, pediatric oncology, pediatric cardiology and cardiothoracic surgery, thoracic insufficiency syndrome, and pediatric airway disorders and transplants. The company was founded by Francis West Lewis in 1855 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | 01/04/2014 |
American Society of Gene & Cell Therapy
 American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | President | - |
Formazione di Katherine High
| Harvard University | Undergraduate Degree |
| University of Pennsylvania | Graduate Degree |
| UNC School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| CRISPR THERAPEUTICS AG | Health Technology |
| Aziende private | 6 |
|---|---|
Asklepios BioPharmaceutical, Inc.
Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Health Technology |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
The Children's Hospital of Philadelphia
The Children's Hospital of Philadelphia Hospital/Nursing ManagementHealth Services The Children's Hospital of Philadelphia provides health care services. It specializes in pediatrics, research, fetal surgery, pediatric oncology, pediatric cardiology and cardiothoracic surgery, thoracic insufficiency syndrome, and pediatric airway disorders and transplants. The company was founded by Francis West Lewis in 1855 and is headquartered in Philadelphia, PA. | Health Services |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Commercial Services |
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE. | Health Technology |
| Innovative Genomics Institute |
- Borsa valori
- Insiders
- Katherine High
